JOSEPH SIMPSON: Open Payments
NPI 1558399378 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,515 in 134 payments from 18 companies in 2025. Trend: 2023 $3,900 · 2024 $4,057 · 2025 $3,515
Food & beverage: $3,515
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 23 | $815 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $598 |
| Neurocrine BioSciences, Inc. | 12 | $304 |
| ABBVIE INC. | 5 | $288 |
| E.R. Squibb & Sons, L.L.C. | 4 | $265 |
| Janssen Pharmaceuticals, Inc | 7 | $193 |
| Otsuka America Pharmaceutical, Inc. | 12 | $180 |
| Almatica Pharma LLC | 9 | $176 |
| Teva Pharmaceuticals USA, Inc. | 9 | $153 |
| Noven Therapeutics, LLC | 8 | $137 |
Products named: Auvelity, CAPLYTA, INGREZZA, VRAYLAR, REXULTI, COBENFY, SPRAVATO, LOREEV XR.
Industry payments across TX — which companies pay providers there.
